BRCA1 and ovarian cancer: Deleterious mutations in BRCA1 or BRCA2 lead to defects in DNA damage repair due to homologous recombination deficiency, resulting in a high penetrance for both breast and ovarian cancer following an autosomal-dominant inheritance pattern [9–12].